DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $56.1B
1-Year Return 19.33%
This Quarter Return
+5.96%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$30.1B
AUM Growth
+$3.48B
Cap. Flow
+$2.16B
Cap. Flow %
7.16%
Top 10 Hldgs %
23.19%
Holding
1,423
New
92
Increased
671
Reduced
310
Closed
81

Sector Composition

1 Technology 24.75%
2 Healthcare 15.88%
3 Financials 12.34%
4 Communication Services 9.65%
5 Industrials 8.34%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SNDR icon
1076
Schneider National
SNDR
$4.26B
$375K ﹤0.01%
+14,909
New +$375K
CDXS icon
1077
Codexis
CDXS
$220M
$372K ﹤0.01%
18,000
OCUL icon
1078
Ocular Therapeutix
OCUL
$2.24B
$361K ﹤0.01%
22,900
ZGNX
1079
DELISTED
Zogenix, Inc.
ZGNX
$356K ﹤0.01%
18,600
KPTI icon
1080
Karyopharm Therapeutics
KPTI
$54.4M
$355K ﹤0.01%
2,413
PTGX icon
1081
Protagonist Therapeutics
PTGX
$3.62B
$354K ﹤0.01%
14,000
TTC icon
1082
Toro Company
TTC
$7.73B
$354K ﹤0.01%
3,405
ZIXI
1083
DELISTED
Zix Corporation
ZIXI
$352K ﹤0.01%
48,800
NRIX icon
1084
Nurix Therapeutics
NRIX
$697M
$351K ﹤0.01%
12,400
TVTX icon
1085
Travere Therapeutics
TVTX
$1.9B
$351K ﹤0.01%
14,500
QTTB icon
1086
Q32 Bio
QTTB
$21.5M
$350K ﹤0.01%
2,139
KEP icon
1087
Korea Electric Power
KEP
$17.8B
$349K ﹤0.01%
34,974
PFPT
1088
DELISTED
Proofpoint, Inc.
PFPT
$345K ﹤0.01%
2,800
CVE icon
1089
Cenovus Energy
CVE
$29.5B
$344K ﹤0.01%
45,343
+5,466
+14% +$41.5K
NTCT icon
1090
NETSCOUT
NTCT
$1.79B
$342K ﹤0.01%
12,240
QNCX icon
1091
Quince Therapeutics
QNCX
$86.5M
$339K ﹤0.01%
10,000
AKRO icon
1092
Akero Therapeutics
AKRO
$3.53B
$338K ﹤0.01%
12,000
SQM icon
1093
Sociedad Química y Minera de Chile
SQM
$12B
$337K ﹤0.01%
6,200
ARQT icon
1094
Arcutis Biotherapeutics
ARQT
$2.15B
$334K ﹤0.01%
12,400
RDWR icon
1095
Radware
RDWR
$1.1B
$334K ﹤0.01%
13,150
ICL icon
1096
ICL Group
ICL
$7.86B
$332K ﹤0.01%
56,626
+1,153
+2% +$6.76K
RBA icon
1097
RB Global
RBA
$21.5B
$330K ﹤0.01%
5,682
-84
-1% -$4.88K
NKTX icon
1098
Nkarta
NKTX
$147M
$329K ﹤0.01%
10,500
TVRD
1099
Tvardi Therapeutics, Inc. Common Stock
TVRD
$286M
$329K ﹤0.01%
450
CEO
1100
DELISTED
CNOOC Limited
CEO
$329K ﹤0.01%
+3,110
New +$329K